6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
15m ago	Timberland Bancorp Reports Second Fiscal Quarter Net Income of $7.1 Million
41m ago	CPKC increases dividend by 17.5 percent
41m ago	Waldencast announces conclusion of SEC investigation
42m ago	Nektar to Announce Financial Results for the First Quarter on Thursday, May 7, 2026, After Close of U.S.-Based Financial Markets
42m ago	F5 to Host Analyst and Investor Meeting on May 28, 2026

About

Viridian Therapeutics Inc (NASDAQ:VRDN) — investor relations, events, news, and company updates on 6ix.

Latest News

Viridian Therapeutics Announces Positive Topline Results from Elegrobart Phase 3 REVEAL‑1 Clinical Trial in Active Thyroid Eye Disease

Bambusa Therapeutics Appoints Todd James Chief Financial Officer

Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2025 Financial Results

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Viridian Therapeutics Prepares for Transformational 2026

Financials

Revenue

$70.85 M

Market Cap

$1.93 B

EPS

-3.32

Community Chat

Ask AI